Diabetes Care, Vol 22, Issue 6 913-919, Copyright © 1999 by American Diabetes Association

ARTICLES

Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial

V Vuksan, DJ Jenkins, P Spadafora, JL Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, LA Leiter and C Bruce-Thompson
Department of Nutritional Sciences, St. Michael's Hospital, Faculty of Medicine, University of Toronto, Ontario, Canada. v.vuksan@utoronto.ca

OBJECTIVE: To examine whether Konjac-mannan (KJM) fiber improves metabolic control as measured by glycemia, lipidemia, and blood pressure in high-risk type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A total of 11 hyperlipidemic and hypertensive type 2 diabetic patients treated conventionally by a low-fat diet and drug therapy participated. After an 8-week baseline, all were randomly assigned to take either KJM fiber-enriched test biscuits (0.7 g/412 kJ [100 kcal] of glucomannan) or matched placebo wheat bran fiber biscuits during two 3-week treatment phases separated by a 2-week washout period. The diet in either case was metabolically controlled and conformed to National Cholesterol Education Program Step 2 guidelines, while medications were maintained constant. Efficacy measures included serum fructosamine, lipid profiles, apolipoproteins, blood pressure, body weight, and nutritional analysis. RESULTS: Compared with placebo, KJM significantly reduced the metabolic control primary end points: serum fructosamine (5.7%, P = 0.007, adjusted alpha = 0.0167), total:HDL cholesterol ratio (10%, P = 0.03, adjusted alpha = 0.05), and systolic blood pressure (sBP) (6.9%, P = 0.02, adjusted alpha = 0.025). Secondary end points, including body weight, total, LDL, and HDL cholesterol, triglycerides, apolipoproteins A-1, B, and their ratio, glucose, insulin, and diastolic blood pressure, were not significant after adjustment by the Bonferroni-Hochberg procedure. CONCLUSIONS: KJM fiber added to conventional treatment may ameliorate glycemic control, blood lipid profile, and sBP in high-risk diabetic individuals, possibly improving the effectiveness of conventional treatment in type 2 diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. D. Azezli, T. Bayraktaroglu, and Y. Orhan The Use of Konjac Glucomannan to Lower Serum Thyroid Hormones in Hyperthyroidism J. Am. Coll. Nutr., December 1, 2007; 26(6): 663 - 668. [Abstract] [Full Text] [PDF]

				M. A. Pereira, E. O'Reilly, K. Augustsson, G. E. Fraser, U. Goldbourt, B. L. Heitmann, G. Hallmans, P. Knekt, S. Liu, P. Pietinen, et al. Dietary Fiber and Risk of Coronary Heart Disease: A Pooled Analysis of Cohort Studies Arch Intern Med, February 23, 2004; 164(4): 370 - 376. [Abstract] [Full Text] [PDF]

				D. J. Jenkins, C. W. Kendall, A. Marchie, A. L Jenkins, L. S. Augustin, D. S Ludwig, N. D Barnard, and J. W Anderson Type 2 diabetes and the vegetarian diet Am. J. Clinical Nutrition, September 1, 2003; 78(3): 610S - 616. [Abstract] [Full Text] [PDF]

				D. Geleva, W. Thomas, M. C. Gannon, and J. M. Keenan A Solubilized Cellulose Fiber Decreases Peak Postprandial Cholecystokinin Concentrations after a Liquid Mixed Meal in Hypercholesterolemic Men and Women J. Nutr., July 1, 2003; 133(7): 2194 - 2203. [Abstract] [Full Text] [PDF]

				H.-L. Chen, W. H.-H. Sheu, T.-S. Tai, Y.-P. Liaw, and Y.-C. Chen Konjac Supplement Alleviated Hypercholesterolemia and Hyperglycemia in Type 2 Diabetic Subjects--A Randomized Double-Blind Trial J. Am. Coll. Nutr., February 1, 2003; 22(1): 36 - 42. [Abstract] [Full Text] [PDF]

				V. Vuksan, J. L. Sievenpiper, Z. Xu, E. Y. Y. Wong, A. L. Jenkins, U. Beljan-Zdravkovic, L. A. Leiter, R. G. Josse, and M. P. Stavro Konjac-Mannan and American Ginsing: Emerging Alternative Therapies for Type 2 Diabetes Mellitus J. Am. Coll. Nutr., October 1, 2001; 20(90005): 370S - 380. [Abstract] [Full Text]

				V. Vuksan, M. P Stavro, J. L Sievenpiper, V. Y. Koo, E. Wong, U. Beljan-Zdravkovic, T. Francis, A. L Jenkins, L. A Leiter, R. G Josse, et al. American Ginseng Improves Glycemia in Individuals with Normal Glucose Tolerance: Effect of Dose and Time Escalation J. Am. Coll. Nutr., June 1, 2000; 19(6): 738 - 744. [Abstract] [Full Text] [PDF]

				Z. X Lu, K. Z Walker, J. G Muir, T. Mascara, and K. O'Dea Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1123 - 1128. [Abstract] [Full Text] [PDF]